Check-Cap
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch Check-Cap and buy or sell other stocks, ETFs, and their options commission-free!About CHEK
Check-Cap Ltd. is a clinical stage medical diagnostics company, which engages in the development of ingestible imaging capsule systems for colorectal cancer screening. Its patented technology, C-Scan, is a patient-friendly preparation-free test designed to detect polyps before they may transform into cancer.
CEODavid Lontini
CEODavid Lontini
Employees—
Employees—
HeadquartersIsfiya, Haifa
HeadquartersIsfiya, Haifa
Founded2005
Founded2005
Employees—
Employees—
CHEK Key Statistics
Market cap12.29M
Market cap12.29M
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume1.16M
Average volume1.16M
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$3.13
52 Week high$3.13
52 Week low$0.56
52 Week low$0.56
Stock Snapshot
With a market cap of 12.29M, Check-Cap(CHEK) trades at $1.61.
On 2025-12-05, Check-Cap(CHEK) shares started trading at —, with intraday highs of — and lows of —.
Trading activity shows a volume of 0, compared to an average daily volume of 1.16M.
The stock's 52-week range extends from a low of $0.56 to a high of $3.13.
The stock's 52-week range extends from a low of $0.56 to a high of $3.13.
People also own
Based on the portfolios of people who own CHEK. This list is generated using Robinhood data, and it’s not a recommendation.